Newsfeeds - Spark Newswire

1 minute read

Acadia Healthcare Co Q4 Adj. EPS $0.74 Misses $0.75 Estimate, Sales $675.29M Beat $660.42M Estimate

Today, 4:05 PM

Acadia Healthcare Co (NASDAQ:ACHC) reported quarterly earnings of $0.74 per share which missed the analyst consensus estimate of $0.75 by 1.33 percent. This is a 8.64 percent decrease over earnings of $0.81 per share

ACHC

15 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022

By Benzinga Insights

Today, 4:05 PM

Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…

ACHC

1 minute read

Loop Capital Upgrades Acadia Healthcare Co to Buy, Announces $95 Price Target

By Benzinga Newsdesk

Today, 4:05 PM

Loop Capital analyst Joseph France upgrades Acadia Healthcare Co (NASDAQ:ACHC) from Hold to Buy and announces $95 price target.

ACHC

1 minute read

Stephens & Co. Maintains Equal-Weight on Acadia Healthcare Co, Raises Price Target to $86

By Benzinga Newsdesk

Today, 4:05 PM

Stephens & Co. analyst Scott Fidel maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Equal-Weight and raises the price target from $85 to $86.

ACHC

1 minute read

Earnings

Earnings Outlook For Acadia Healthcare Co

By Benzinga Insights

Today, 4:05 PM

Acadia Healthcare Co (NASDAQ:ACHC) is set to give its latest quarterly earnings report on Monday, 2022-10-31. Here's what investors need to know before the announcement. Analysts estimate that Acadia Healthcare Co will report an earnings per share (EPS) of $0.79.

ACHC

1 minute read

Seelos Therapeutics Announces Participation Of Acadia Healthcare In The Registration Directed Study Of SLS-002 (Intranasal Racemic Ketamine) For Acute Suicidal Ideation And Behavior In Patients With Major Depressive Disorder

By Bill Haddad

Today, 4:05 PM

NEW YORK, Sept. 13, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases,

ACHC

1 minute read

SVB Leerink Maintains Outperform on Acadia Healthcare Co, Raises Price Target to $103

By Benzinga Newsdesk

Today, 4:05 PM

SVB Leerink analyst Whit Mayo maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Outperform and raises the price target from $95 to $103.

ACHC

1 minute read

Acadia Healthcare Earns 12% Price Target Bump ‘On Strong Q2’

By Vandana Singh

Today, 4:05 PM

RBC Capital Markets raised the price target on Acadia Healthcare Company Inc (NASDAQ:ACHC) to $94 from $84 with an Outperform rating unchanged.…

ACHC

1 minute read

Raymond James Maintains Strong Buy on Acadia Healthcare Co, Raises Price Target to $100

By Benzinga Newsdesk

Today, 4:05 PM

Raymond James analyst John Ransom maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Strong Buy and raises the price target from $85 to $100.

ACHC

1 minute read

Analyst Ratings

5 Analysts Have This to Say About Acadia Healthcare Co

By Benzinga Insights

Today, 4:05 PM

Over the past 3 months, 5 analysts have published their opinion on Acadia Healthcare Co (NASDAQ:ACHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ACHC